Predict your next investment

Corporation
rqbglobal.com

See what CB Insights has to offer

Partners & Customers

5

About RavenQuest BioMed

RavenQuest Biomed is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.

RavenQuest BioMed Headquarter Location

Canada

604-484-1230

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RavenQuest BioMed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find RavenQuest BioMed in 1 Expert Collection, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest RavenQuest BioMed News

IIROC Trading Halt - RQB

Jun 4, 2020

IIROC Trading Halt - RQB VANCOUVER, BC, June 4, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Ravenquest BioMed Inc. Author: VANCOUVER, BC, June 4, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Ravenquest BioMed Inc. Reason: CTO Halt Time (ET): 7:55 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

RavenQuest BioMed Acquisitions

4 Acquisitions

RavenQuest BioMed acquired 4 companies. Their latest acquisition was 1 Life Cannabis on January 03, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/3/2019

$99M

Corporate Majority

2

6/6/2018

Subscribe to see more

$99M

Subscribe to see more

10

3/2/2018

Subscribe to see more

$99M

Subscribe to see more

10

10/26/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/3/2019

6/6/2018

3/2/2018

10/26/2017

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Total Funding

Note

Corporate Majority

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

RavenQuest BioMed Partners & Customers

5 Partners and customers

RavenQuest BioMed has 5 strategic partners and customers. RavenQuest BioMed recently partnered with Health Canada on September 9, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

9/26/2019

Licensor

Canada

RAVENQUEST PARTNER MCGILL UNIVERSITY SECURES CANNABIS LICENSE - RavenQuest BioMed Inc : RavenQuest BioMed Inc

RavenQuest BioMed Inc. CEO , George Robinson , commented that `` throughout our partnership with McGill University , research has thus far uncovered several key beneficial microbes which have shown significant potential to improve yield and disease resistance .

2

9/16/2019

Partner

Canada

Subscribe to see more

Subscribe to see more

10

4/10/2019

Client

Canada

Subscribe to see more

Subscribe to see more

10

12/18/2018

Client

Canada

Subscribe to see more

Subscribe to see more

10

8/15/2018

Partner

Canada

Subscribe to see more

Subscribe to see more

10

Date

9/26/2019

9/16/2019

4/10/2019

12/18/2018

8/15/2018

Type

Licensor

Partner

Client

Client

Partner

Business Partner

Country

Canada

Canada

Canada

Canada

Canada

News Snippet

RAVENQUEST PARTNER MCGILL UNIVERSITY SECURES CANNABIS LICENSE - RavenQuest BioMed Inc : RavenQuest BioMed Inc

RavenQuest BioMed Inc. CEO , George Robinson , commented that `` throughout our partnership with McGill University , research has thus far uncovered several key beneficial microbes which have shown significant potential to improve yield and disease resistance .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.